Literature DB >> 24045153

A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif.

Mark Linch1, Marta Sanz-Garcia, Erika Soriano, Yixiao Zhang, Philippe Riou, Carine Rosse, Angus Cameron, Phillip Knowles, Andrew Purkiss, Svend Kjaer, Neil Q McDonald, Peter J Parker.   

Abstract

Atypical protein kinase Cι (PKCι) has roles in cell growth, cellular polarity, and migration, and its abundance is frequently increased in cancer. We identified a protein interaction surface containing a dibasic motif (RIPR) that bound a distinct subset of PKCι substrates including lethal giant larvae 2 (LLGL2) and myosin X, but not other substrates such as Par3. Further characterization demonstrated that Arg471 in this motif was important for binding to LLGL2, whereas Arg474 was critical for interaction with myosin X, indicating that multiple complexes could be formed through this motif. A somatic mutation of the dibasic motif (R471C) was the most frequent mutation of PKCι in human cancer, and the intact dibasic motif was required for normal polarized epithelial morphogenesis in three-dimensional cysts. Thus, the R471C substitution is a change-of-function mutation acting at this substrate-specific recruitment site to selectively disrupt the polarizing activity of PKCι.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045153     DOI: 10.1126/scisignal.2004068

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  15 in total

Review 1.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 2.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

Review 3.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

Review 4.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

Review 5.  Protein kinase C in cancer: The top five unanswered questions.

Authors:  Mariana Cooke; Andrew Magimaidas; Victoria Casado-Medrano; Marcelo G Kazanietz
Journal:  Mol Carcinog       Date:  2017-03-10       Impact factor: 4.784

6.  Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Authors:  Corina E Antal; Andrew M Hudson; Emily Kang; Ciro Zanca; Christopher Wirth; Natalie L Stephenson; Eleanor W Trotter; Lisa L Gallegos; Crispin J Miller; Frank B Furnari; Tony Hunter; John Brognard; Alexandra C Newton
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

Review 7.  Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.

Authors:  Alexandra C Newton; John Brognard
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

Review 8.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

9.  Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.

Authors:  Yi Liu; Verline Justilien; Alan P Fields; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2020-09-12

10.  Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Sibao Wan; ShaoPeng Wang; Xiang-Yin Kong
Journal:  Biomed Res Int       Date:  2015-11-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.